Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Techne Corp (TECH : NSDQ)
 
 • Company Description   
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Number of Employees: 2,600

 
 • Price / Volume Information   
Yesterday's Closing Price: $366.35 Daily Weekly Monthly
20 Day Moving Average: 285,683 shares
Shares Outstanding: 39.23 (millions)
Market Capitalization: $14,373.20 (millions)
Beta: 1.24
52 Week High: $543.85
52 Week Low: $335.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -9.09% -0.46%
12 Week -13.33% -2.59%
Year To Date -29.19% -13.49%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
614 MCKINLEY PLACE NE
-
MINNEAPOLIS,MN 55413
USA
ph: 612-379-8854
fax: 612-656-4400
ir@bio-techne.com http://www.bio-techne.com
 
 • General Corporate Information   
Officers
Charles Kummeth - President and CEO
Robert V. Baumgartner - Chairman of the Board and Director
James Hippel - Executive Vice President and Chief Financial Offic
Brenda Furlow - Executive Vice President; General Counsel and Corp
Rupert Vessey - Director

Peer Information
Bio-Techne Corp (CORR.)
Bio-Techne Corp (RSPI)
Bio-Techne Corp (CGXP)
Bio-Techne Corp (BGEN)
Bio-Techne Corp (GTBP)
Bio-Techne Corp (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09073M104
SIC: 2836
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 39.23
Most Recent Split Date: 12.00 (2.00:1)
Beta: 1.24
Market Capitalization: $14,373.20 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.35%
Current Fiscal Quarter EPS Consensus Estimate: $1.89 Indicated Annual Dividend: $1.28
Current Fiscal Year EPS Consensus Estimate: $7.03 Payout Ratio: 0.19
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: -0.12
Estmated Long-Term EPS Growth Rate: 26.00% Last Dividend Paid: 05/13/2022 - $0.32
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 52.08
Trailing 12 Months: 53.95
PEG Ratio: 2.00
Price Ratios
Price/Book: 8.40
Price/Cash Flow: 44.58
Price / Sales: 13.35
EPS Growth
vs. Year Ago Period: 21.74%
vs. Previous Quarter: 22.50%
Sales Growth
vs. Year Ago Period: 19.23%
vs. Previous Quarter: 7.84%
ROE
03/31/22 - 16.82
12/31/21 - 16.35
09/30/21 - 15.86
ROA
03/31/22 - 12.21
12/31/21 - 11.85
09/30/21 - 11.50
Current Ratio
03/31/22 - 3.56
12/31/21 - 3.81
09/30/21 - 4.06
Quick Ratio
03/31/22 - 2.79
12/31/21 - 3.03
09/30/21 - 3.18
Operating Margin
03/31/22 - 25.92
12/31/21 - 25.67
09/30/21 - 25.35
Net Margin
03/31/22 - 20.95
12/31/21 - 20.45
09/30/21 - 17.94
Pre-Tax Margin
03/31/22 - 21.32
12/31/21 - 20.01
09/30/21 - 17.90
Book Value
03/31/22 - 43.61
12/31/21 - 43.33
09/30/21 - 42.14
Inventory Turnover
03/31/22 - 2.84
12/31/21 - 2.84
09/30/21 - 2.83
Debt-to-Equity
03/31/22 - 0.14
12/31/21 - 0.16
09/30/21 - 0.17
Debt-to-Capital
03/31/22 - 12.58
12/31/21 - 13.67
09/30/21 - 14.87
 

Powered by Zacks Investment Research ©